Judith A Mcnicholas, MD Obstetrics & Gynecology - Female Pelvic Medicine and Reconstructive Surgery Medicare: Accepting Medicare Assignments Practice Location: 900 Union St, Westborough, MA 01581 Phone: 508-871-0700 Fax: 508-616-4411 |
Margaret R Hines, MD Obstetrics & Gynecology - Female Pelvic Medicine and Reconstructive Surgery Medicare: Accepting Medicare Assignments Practice Location: 900 Union St, Westborough, MA 01581 Phone: 508-870-9350 Fax: 508-368-3917 |
Darshana Mandar Apte, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 106 E Main St, Westborough, MA 01581 Phone: 508-871-0780 Fax: 508-366-6744 |
News Archive
Many elderly people spend their last years alone. Spouses pass and children scatter. But being lonely is much more than a silent house and a lack of companionship. Over time, loneliness not only takes a toll on the psyche but can have a serious physical impact as well.
Modern Healthcare: "Sen. Chuck Grassley (R-Iowa) has sent a letter asking 31 hospitals to report on their relationships with healthcare IT vendors, focusing on errors caused by IT systems and on so-called 'gag order or non-disclosure clauses' in vendor contracts that might prohibit the hospitals from disclosing information about system flaws." Grassley made a similar request to the IT vendors themselves last fall, and said his new letter was prompted by concern about taxpayers' investment in health IT as part of the economic stimulus (Conn, 1/20).
The La Jolla Institute for Immunology (LJI) is partnering with Synbal, Inc., a preclinical biotechnology company based in San Diego, CA, to develop multi-gene, humanized mouse models for COVID-19 research. The research at LJI will be led by Professor Sujan Shresta, Ph.D., a member of the Institute's Center for Infectious Disease and Vaccine Research.
Malaria is one of the most serious health problems worldwide, registering 200 million clinical cases and more than 600,000 attributable deaths per year, according to information from the World Health Organization in 2013. Given the emerging resistance to the standard treatment most widely used throughout the world, which is based on artemisinin and its analogs, there is a need for new antimalarial compounds.
› Verified 5 days ago